BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma
Clinical trial NCT01638936 · COMPLETED
Trial details
- NCT number
- NCT01638936
- Sponsor
- Biotest Pharmaceuticals Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-03
- Primary completion
- 2018-10-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.